Clinical prolife and outcome in COVID-19 patients on treatment regimen of remdesivir, favipiravir, and non-antiviral drugs
Background: Although various drugs have been used in the treatment of COVID-19 infections, specific drug with good therapeutic outcome is still unclear. They are using remdesivir, favipiravir, ivermectin, azithromycin, and so on. Aim and Objectives: This study aimed to evaluate the clinical profile...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Eldaghayes Publisher
2023-07-01
|
| Collection: | National Journal of Physiology, Pharmacy and Pharmacology |
| Sujets: | |
| Accès en ligne: | http://www.ejmanager.com/fulltextpdf.php?mno=153039 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|